日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The first World Health Organization International Standard for infliximab products: A step towards maintaining harmonized biological activity.

世界卫生组织首个英夫利昔单抗产品国际标准:迈向维持生物活性一致性的一步

Metcalfe Clive, Dougall Thomas, Bird Chris, Rigsby Peter, Behr-Gross Marie-Emmanuelle, Wadhwa Meenu, Study Participants Of The

International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab

支持上市前和上市后产品一致性的单克隆抗体国际标准:利妥昔单抗生物活性候选国际标准的评估

Prior, Sandra; Hufton, Simon E; Fox, Bernard; Dougall, Thomas; Rigsby, Peter; Bristow, Adrian

Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study

建立首个世界卫生组织呼吸道合胞病毒抗血清国际标准:一项国际合作研究报告

McDonald, Jacqueline U; Rigsby, Peter; Dougall, Thomas; Engelhardt, Othmar G

The establishment of a WHO Reference Reagent for anti-malaria (Plasmodium falciparum) human serum

建立世界卫生组织抗疟疾(恶性疟原虫)人血清参考试剂

Bryan, Donna; Silva, Nilupa; Rigsby, Peter; Dougall, Thomas; Corran, Patrick; Bowyer, Paul W; Ho, Mei Mei

Establishment of the first international standard for PEGylated granulocyte colony stimulating factor (PEG-G-CSF): report of an international collaborative study

建立首个聚乙二醇化粒细胞集落刺激因子(PEG-G-CSF)国际标准:一项国际合作研究的报告

Wadhwa, Meenu; Bird, Chris; Dougall, Thomas; Rigsby, Peter; Bristow, Adrian; Thorpe, Robin